30 results on '"Ierardi E"'
Search Results
2. Letter: could sequential therapy extended to 14 days replace prolonged triple regimens for Helicobacter pylori treatment?
3. Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication: the meta-analysis may be influenced by ‘geographical weighting’
4. Letter: tumour necrosis factor alpha blocker switching – a not so simple pharmacokinetic
5. Gastroenterology: Video capsule endoscopy disclosure of unprecedented therapeutic effect of Eviendep on small bowel polyposis in Lynch syndrome
6. Letter: portal vein obstruction – which subset of patients could benefit the most?
7. Letter: Helicobacter-negative gastritis – a distinct condition?
8. Expression of basic fibroblastic growth factor, syndecan 1 and tumour necrosis factor α in resected acute colonic diverticulitis
9. AN OVERVIEW OF ANTIBIOTIC PHENOTYPIC RESISTANCES TO HELICOBACTER PYLORI (HP) IN SOUTHERN ITALY: MAY TIGECYCLINE BE THE "DRUG OF THE FUTURE?: Abstract no.: P13.12
10. Mucosal expression of basic fibroblastic growth factor, Syndecan 1 and tumor necrosis factor-alpha in diverticular disease of the colon: a case–control study
11. Musosal tumour necrosis factor α in diverticular disease of the colon is overexpressed with disease severity
12. Endoscopic dilatation in Crohnʼs disease
13. Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial
14. Tumour necrosis factor α downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula
15. Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction
16. DNA sequences and proteic antigens of H. pylori in cholecystic bile and tissue of patients with gallstones
17. A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses
18. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study
19. Epithelial cell proliferation of the colonic mucosa in diverticular disease: a case–control study
20. Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia
21. Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure
22. Endoscopic ultrasound localization of a solitary insulinoma of pancreatic tail misdiagnosed as epilepsy: case report
23. Mycophenolate mofetil in the treatment of autoimmune HCV-associated haematological disorders showing steroid resistance or dependence
24. Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy
25. High eradication rates of Helicobacter pylori with a new sequential treatment
26. Second harmonic imaging improves trans-abdominal ultrasound detection of biliary sludge in ‘idiopathic’ pancreatitis
27. Helicobacter pylori strains and histologically-related lesions affect the outcome of triple eradication therapy: a study from southern Italy
28. Helicobacter heilmannii gastritis: a histological and immunohistochemical trait
29. Oral tacrolimus long-term therapy in patients with Crohn’s disease and steroid resistance
30. Proliferative Activity of Gastric Epithelium in Progressive Stages of Helicobacter pylori Infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.